er hat schon Recht wenn er sagt das ihr euch selber im Weg steht.
eure Überlegungen sind zwar gut und ihr könnt auch sezieren - aber ihr habt kein Gespühr für das Wesentliche!
und nur damit wird Geld gemacht.
MEINE MEINUNG
Associated Press
Cerus, Baxter Intend Larger BioOne Deal
Wednesday January 5, 11:10 am ET
CONCORD, Calif. (AP) -- Cerus Corp. reported Wednesday that it and units of health-care products company Baxter International Inc. agreed to allow BioOne Corp. to commercialize their Intercept blood system for plasma products in Asia.
Cerus, which co-developed Intercept with marketing partner Baxter, received an upfront payment of $3 million for signing a letter of intent. The companies are in talks for a definitive agreement.
Cerus and Baxter received $15 million in October from BioOne to commercialize the pathogen inactivation technology in Japan, China, Taiwan, South Korea, Thailand, Vietnam and Singapore for platelet products. The new agreement covers plasma products in the same countries.
Shares of Cerus rose 2 cents to $3.33 in morning trading on the Nasdaq. Baxter shares rose 69 cents, or 2 percent, to $35.24 on the New York Stock Exchange.
DEERFIELD, Ill. (AP) -- IV supplies maker Baxter International Inc. and Cerus Corp., a developer of blood-safety technology, said Thursday they agreed to market and develop the Intercept blood system in Europe at least through 2006, and resolved their loan dispute and related legal actions.
Under a separate agreement, Cerus will immediately pay $34.5 million to Baxter Capital Corp. and provide a promissory note for $4.5 million, payable with interest in December 2006. Baxter Capital has agreed these payments satisfy the loan obligation.
The companies said this deal doesn't change their relationship with Asian partner, BioOne Corp. In 2004, the companies announced an agreement under which BioOne would market and distribute the Intercept blood system for platelets in Japan, China, Taiwan, South Korea, Thailand, Vietnam and Singapore.
Baxter shares rose 34 cents to $34.31 in afternoon trading on the New York Stock Exchange. Cerus shares rose 13 cents, or 3.5 percent, to $3.90 on the Nasdaq.
|
Wertung | Antworten | Thema | Verfasser | letzter Verfasser | letzter Beitrag | |
70 | Bio One | Possibility | Kicky | 18.04.05 21:10 | ||
7 | Wer hat was gutes auf der Watchlist? | RealDOJO | Janasde | 03.12.04 17:50 |